Heron Financial Group, LLC Perkinelmer Inc Transaction History

Heron Financial Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$120.16 - $144.38 $45,060 - $54,142	-375 Reduced 19.0%	1,599 $213,000
Q4 2022 Feb 14, 2023	SELL	$119.0 - $147.98 $17,850 - $22,197	-150 Reduced 7.06%	1,974 $276,000
Q2 2022 Jul 29, 2022	SELL	$134.91 - $172.49 $20,776 - $26,563	-154 Reduced 6.76%	2,124 $302,000
Q1 2021 Apr 14, 2021	SELL	$120.35 - $160.53 $2,045 - $2,729	-17 Reduced 0.74%	2,278 $296,000
Q4 2020 Feb 16, 2021	SELL	$122.05 - $147.91 $39,910 - $48,366	-327 Reduced 12.47%	2,295 $368,000
Q3 2020 Oct 15, 2020	SELL	$97.09 - $125.51 $12,621 - $16,316	-130 Reduced 4.72%	2,622 $340,000
Q2 2020 Jul 20, 2020	SELL	$70.83 - $105.31 $23,728 - $35,278	-335 Reduced 10.85%	2,752 $279,000
Q4 2019 Feb 14, 2020	BUY	$79.1 - $97.45 $244,181 - $300,828	3,087 New	3,087 $296,000

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Heron Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Heron Financial Group, LLC with notifications on news.